Michael Peterson, DO
Dermatology · Spanish Fork, UTNPI 1770634909
Payments from drug & device makers
Across 1,007 payments — averaging $1631.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$851K
- Pfizer$397K
- Janssen Research & Development, LLC$68K
- Sanofi US Services Inc.$63K
- Incyte Corporation$60K
- E.r. Squibb & Sons, L.L.C.$59K
- plus $146K from 30 others
Across 2 payments — averaging $265,259 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nielsen Biosciences, Inc.$531K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 493 | $850,701 |
| Pfizer | 87 | $396,578 |
| Janssen Research & Development, LLC | 7 | $68,345 |
| Sanofi US Services Inc. | 10 | $62,809 |
| Incyte Corporation | 13 | $59,703 |
| E.r. Squibb & Sons, L.L.C. | 9 | $58,809 |
| GSK | 12 | $40,297 |
| Amgen | 16 | $37,226 |
| Taro Pharmaceuticals USA, Inc. | 5 | $26,500 |
| AbbVie | 128 | $18,506 |
| Sun Pharmaceutical Industries Inc. | 24 | $17,867 |
| UCB, Inc. | 11 | $1,525 |
| Johnson & Johnson | 32 | $708 |
| Lilly USA, LLC | 26 | $496 |
| Novartis | 21 | $394 |
| Dermavant Sciences, Inc. | 9 | $318 |
| Galderma Laboratories, L.p. | 26 | $300 |
| Biofrontera Inc. | 13 | $274 |
| LEO Pharma Inc. | 10 | $223 |
| Arcutis Biotherapeutics, Inc. | 11 | $185 |
| Regeneron Healthcare Solutions, Inc. | 9 | $173 |
| Sanofi | 9 | $172 |
| VYNE Pharmaceuticals Inc. | 2 | $118 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $113 |
| Boston Scientific | 2 | $67 |
| Organon | 5 | $60 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $57 |
| EPI Health, LLC | 2 | $41 |
| Organogenesis Inc. | 1 | $31 |
| Dermira, Inc. | 2 | $29 |
| Strata Skin Sciences, Inc. | 2 | $23 |
| Springworks Therapeutics, Inc. | 1 | $19 |
| Medtronic | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Johnson & Johnson Vision Care, Inc. | 1 | $13 |
| Janssen Scientific Affairs, LLC | 1 | $6 |
How this compares
$1,642,718 in reported general payments places this provider in the 95th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Spanish Fork
- Jamie RhoadsMurray$2.5M
- Doug Lass ForshaWest Jordan$2.2M
- Kristina DuffinSalt Lake City$1.2M
- Gerald KruegerSalt Lake City$1.1M
- Brian WilliamsMidvale$876K
- Jason HadleyBountiful$477K
- Mark TaylorSalt Lake City$473K
- Travis JamesProvidence$472K
- Douglas WosethSalt Lake$466K
- James MacdonaldLehi$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.